Skip to main content
. 2014 Dec 1;1:17. doi: 10.1186/s40673-014-0017-4

Table 5.

The monthly changes of MRS metabolites in different groups of patients

Cerebellar hemispheres Vermis
NAA/Cr Cho/Cr NAA/Cho NAA/Cr Cho/Cr NAA/Cho
p # 0.471 0.168 0.261 0.693 0.269 0.273
SCA2 0.09 ± 0.17 0.13 ± 0.14 −0.08 ± 0.28 −0.25 ± 0.53 −0.18 ± 0.23 −0.08 ± 0.68
SCA3 −0.04 ± 0.22 −0.04 ± 0.26 0.01 ± 0.61 −0.07 ± 0.20 0.05 ± 0.21 −0.22 ± 0.37
SCA6 0.06 ± 0.22 −0.11 ± 0.16 0.27 ± 0.44 −0.18 ± 0.13 −0.16 ± 0.16 0.00 ± 0.45
MSA-C 0.14 ± 0.59 0.02 ± 0.37 0.33 ± 1.14 0.03 ± 0.32 −0.14 ± 0.36 0.51 ± 0.86

SCA2: Spinocerebellar ataxia type 2; SCA3: Spinocerebellar ataxia type 3; SCA6: Spinocerebellar ataxia type 6; MSA-C: Multiple system atrophy- cerebellar type.

Data are presented as 100X MRS ratios.

#Kruskal-Wallis test.